pyrophosphate

(redirected from diphosphate)
Also found in: Dictionary, Medical, Encyclopedia, Wikipedia.
  • noun

Words related to pyrophosphate

a salt or ester of pyrophosphoric acid

Related Words

References in periodicals archive ?
CMX157 is rapidly and efficiently converted to the active antiviral, TFV diphosphate by liver cells, consistent with its improved antiviral activity and potential for dose reduction
adenosine diphosphate (ADP) 1 mM, nicotinammide adenine dinucleotide phosphate (NADP) 0.
After five days off clopidogrel, the preoperative assay revealed high platelet reactivity in response to adenine diphosphate (ADP) stimulation (MA: 62.
It would also fund the building of seven new plants with a total production capacity of 16 million tonnes per year of phosphate concentrate, sulphuric acid, phosphoric acid, as well as plants to produce calcium monophosphate and calcium diphosphate.
Fructose consumption may lead to increased serum uric acid via phosphorylation of fructose by hepatocytes and generation of adenosine diphosphate which is metabolised to uric acid.
According to the company, ticagrelor is the first reversibly binding oral adenosine diphosphate receptor antagonist.
In addition, the company's calcium diphosphate plant will start production on Nov.
The agonists used most in clinical practice are thrombin, adenosine diphosphate (ADP), epinephrine, collagen, arachidonic acid, and ristocetin.
It measures ex vivo platelet binding to collagen/epinephrine (CEPI) or collagen/adenosine diphosphate (CADP).
Full line of phosphate-based flame retardants includes triphenyl phosphate, resorcirol diphosphate, bisphenyl-A disphosphate, and numerous other phosphate esters, which can be used in PVC, engineering thermoplastics, and other applications.
The scheme will have a production capacity of 16m tonnes per year of phosphate concentrate, sulphuric acid, phosphoric acid, as well as plants to produce calcium monophosphate and calcium diphosphate, with phosphate production expected to start in late 2016.
The Company also highlighted progress in research and development, including updates on selected late-stage clinical programs (Vectibix, motesanib diphosphate (AMG 706), Aranesp, Sensipar, denosumab and AMG 531) and the early-stage pipeline.